Cargando…
Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-β Peptide Injection in Rats
Alzheimer’s disease (AD) is a neurodegenerative pathology associated with aging characterized by the presence of senile plaques and neurofibrillary tangles that finally result in synaptic and neuronal loss. The major component of senile plaques is an amyloid-β protein (Aβ). Recently, we characterize...
Autores principales: | Zussy, Charleine, Brureau, Anthony, Keller, Emeline, Marchal, Stéphane, Blayo, Claire, Delair, Brice, Ixart, Guy, Maurice, Tangui, Givalois, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534645/ https://www.ncbi.nlm.nih.gov/pubmed/23301030 http://dx.doi.org/10.1371/journal.pone.0053117 |
Ejemplares similares
-
Central Role of Glucocorticoid Receptors in Alzheimer’s Disease and Depression
por: Canet, Geoffrey, et al.
Publicado: (2018) -
Is AD a Stress-Related Disorder? Focus on the HPA Axis and Its Promising Therapeutic Targets
por: Canet, Geoffrey, et al.
Publicado: (2019) -
In vivo and ex vivo analyses of amyloid toxicity in the Tc1 mouse model of Down syndrome
por: Naert, Gaëlle, et al.
Publicado: (2017) -
Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer’s Disease
por: Zussy, Charleine, et al.
Publicado: (2022) -
Aminostyrylbenzofuran Directly Reduces Oligomeric Amyloid-β and Reverses Cognitive Deficits in Alzheimer Transgenic Mice
por: Lee, Sang-Hyun, et al.
Publicado: (2014)